Sort By:

Migraine Relief

The purpose of this study will be to evaluate the safety and efficacy of a study drug that aims to provide migraine relief. The study will last approximately 17 weeks with 4 of visits to our office and 1 telephone call.

View Trial Details
Ages 18 - 75
Compensation* $225
Study Topics Migraine

*Compensation for time and travel may be available to those who qualify.

Intranasal Migraine Relief (One Year)

The purpose of this research study is to examine an investigational nasal spray for the treatment of an acute migraine headache. Rochester Clinical Research is currently enrolling individuals over the age of 18 years old who experience 2-8 migraines per month. The study drug is a CGRP receptor blocker administered through a nasal spray. The study will last approximately one year long with 17 visits to our office.

View Trial Details
Ages 18+
Study Topics Migraine

Intranasal Migraine Treatment

The purpose of this research study is to examine an investigational nasal spray for the treatment of one acute migraine headache. Rochester Clinical Research is currently enrolling individuals over the age of 18 years old who experience 2-8 migraines per month. The study drug is a CGRP receptor blocker administered through a nasal spray.

View Trial Details
Ages 18+
Study Topics Migraine